03.22.2016 But evidence for causality remains weak by Parker Brown Staff Writer, MedPage Today Endocrine-disrupting chemicals could be costing the European Union up to €1.5 billion ($1.6 billion) a year because of female reproductive health problems, a new report estimated. Researchers looked at two conditions that they said had the most robust data: uterine fibroids […]